Biomedical Investments

An Israeli venture capital firm that invests in the healthcare sector, focusing on medical devices and biotechnology.

Venture Capital Active Tel Aviv, Israel Est. 1997
Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
total disclosed, rounds participated
Stages

About

Biomedical Investments (BMI) was an Israeli venture capital firm specializing in the healthcare field, including medical devices and biotechnology. The firm focused its investments on startups with breakthrough technologies applicable in emerging therapeutic segments. It was founded in 1997 and headquartered in Tel Aviv, Israel. In 2010, Clal Biotechnology Industries Ltd. acquired Biomedical Investments (1997) Ltd. for NIS 84 million in cash, shares, and warrants.

Portfolio

No portfolio companies in this dataset yet.

Investment activity

1 portfolio exit on record.

Portfolio by sector

Health Tech & Life Sciences2

Q&A

What is Biomedical Investments' primary sector focus?
Biomedical Investments primarily focuses on the Health Tech & Life Sciences sector, with all of its portfolio companies and exits falling within this area.
Can you name some of Biomedical Investments' notable portfolio companies?
Biomedical Investments' portfolio includes Gamida Cell, which specializes in Cellular.
Has Biomedical Investments had any exits?
Yes, Biomedical Investments had an exit in October 2018 with Gamida Cell, which went public on NASDAQ with a valuation of $210M.
What is the typical investment range for Biomedical Investments?
Biomedical Investments typically invests between $1.34M and $16M.
What funding stages does Biomedical Investments typically participate in?
Biomedical Investments has participated in Seed and D Round funding stages.
When was Biomedical Investments founded?
Biomedical Investments was created on startupim in May 2019.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Legal nameBIO MEDICAL INVESTMENTS (1997) LTD.
Founded1997

Acquisitions & public offerings

Acquired by Clal Biotechnology Industries Ltd. 2010-03

Radar intelligence

Patents

EPO2